GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (OTCPK:MKEAF) » Definitions » 3-Year EPS without NRI Growth Rate

Mauna Kea Technologies (Mauna Kea Technologies) 3-Year EPS without NRI Growth Rate : 26.00% (As of Jun. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Mauna Kea Technologies 3-Year EPS without NRI Growth Rate?

Mauna Kea Technologies's EPS without NRI for the six months ended in Jun. 2023 was $0.06.

During the past 3 years, the average EPS without NRI Growth Rate was 26.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 13.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Mauna Kea Technologies was 26.00% per year. The lowest was -11.80% per year. And the median was 11.80% per year.


Competitive Comparison of Mauna Kea Technologies's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Mauna Kea Technologies's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mauna Kea Technologies's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's 3-Year EPS without NRI Growth Rate falls into.



Mauna Kea Technologies 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Mauna Kea Technologies  (OTCPK:MKEAF) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Mauna Kea Technologies 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mauna Kea Technologies (Mauna Kea Technologies) Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (Mauna Kea Technologies) Headlines